v3.26.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital:
Accumulated deficit:
Accumulated other comprehensive income (loss):
Common stock shares:
Beginning balances at Dec. 31, 2024 $ 100,909 $ 498,840 $ (397,965) $ 34  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   34,072      
Settlement of liability classified restricted stock units   9,938      
Issuance under stock-based compensation plans   805      
Issuance under employee stock purchase plan   1,475      
Repurchases of common stock   (27,135)      
Net income 9,162   9,162    
Other comprehensive income (loss), net of tax       1  
Ending balances at Sep. 28, 2025 129,227 517,995 (388,803) 35  
Beginning balances (in shares) at Dec. 31, 2024         100,885,000
Common stock shares:          
Issuance under stock-based compensation plans (in shares)         6,818,000
Issuance under employee stock purchase plan (in shares)         155,000
Repurchases of common stock (in shares)         (2,111,000)
Ending balances (in shares) at Sep. 28, 2025         105,747,000
Beginning balances at Jun. 29, 2025 118,274 513,958 (395,676) (8)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   9,876      
Settlement of liability classified restricted stock units   4,942      
Issuance under stock-based compensation plans   0      
Issuance under employee stock purchase plan   0      
Repurchases of common stock   (10,781)      
Net income 6,873   6,873    
Other comprehensive income (loss), net of tax       43  
Ending balances at Sep. 28, 2025 129,227 517,995 (388,803) 35  
Beginning balances (in shares) at Jun. 29, 2025         104,289,000
Common stock shares:          
Issuance under stock-based compensation plans (in shares)         2,080,000
Issuance under employee stock purchase plan (in shares)         0
Repurchases of common stock (in shares)         (622,000)
Ending balances (in shares) at Sep. 28, 2025         105,747,000
Beginning balances at Dec. 31, 2025 127,841 510,864 (383,039) 16  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   43,027      
Settlement of liability classified restricted stock units   23,821      
Issuance under stock-based compensation plans   0      
Issuance under employee stock purchase plan   1,955      
Repurchases of common stock (44,000) (44,551)      
Net income 18,767   18,767    
Other comprehensive income (loss), net of tax       (37)  
Ending balances at Sep. 27, 2026 $ 170,823 535,116 (364,272) (21)  
Beginning balances (in shares) at Dec. 31, 2025 105,030,947       105,031,000
Common stock shares:          
Issuance under stock-based compensation plans (in shares)         5,616,000
Issuance under employee stock purchase plan (in shares)         187,000
Repurchases of common stock (in shares) (3,300,000)       (3,323,000)
Ending balances (in shares) at Sep. 27, 2026 107,510,546       107,511,000
Beginning balances at Jun. 28, 2026 $ 158,525 523,659 (365,134) 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   15,764      
Settlement of liability classified restricted stock units   9,973      
Issuance under stock-based compensation plans   0      
Issuance under employee stock purchase plan   0      
Repurchases of common stock   (14,280)      
Net income 862   862    
Other comprehensive income (loss), net of tax       (21)  
Ending balances at Sep. 27, 2026 $ 170,823 $ 535,116 $ (364,272) $ (21)  
Beginning balances (in shares) at Jun. 28, 2026         107,560,000
Common stock shares:          
Issuance under stock-based compensation plans (in shares)         1,001,000
Issuance under employee stock purchase plan (in shares)         0
Repurchases of common stock (in shares)         (1,050,000)
Ending balances (in shares) at Sep. 27, 2026 107,510,546       107,511,000